Psyence Group Inc is finalizing agreements with partners in Jamaica to develop its natural psilocybin-based formulations
Chief Scientific Officer Justin Grant said the formulations will be used in observational studies that will give way to rigorous randomized clinical trials
Source: proactiveinvestors.com